Subscribe To
DICE Therapeutics to Participate at Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif., Feb. 08, 2023 (GLOBE NEWSWIRE) — DICE Therapeutics, Inc. (Nasdaq: DICE), a biopharmaceutical company leveraging its proprietary technology platform to build a pipeline of novel oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas, today announced management will participate at the following investor conferences: SVB Securities Global […] The post DICE Therapeutics to Participate at Upcoming Investor Conferences appeared firs...
Read More
Posted: Feb 8 2023, 21:05
Author Name: forextv
Views: 103094